Dr. Vimal K. Parmar

BEST EYE SPECIALIST IN PUNE

(M.B.B.S., D.O.M.S.,M.S., FMRF.,FVRF, SRTF)

Meet our distinguished leader, Dr. Vimal K Parmar, a Vitreo-Retinal Surgeon and an esteemed fellow of Sankara Nethralaya. Dr. Parmar's legacy as a prominent eye specialist in Pune and his expertise in anterior and posterior segment surgeries have made him a guiding light in the field of ophthalmology.

With a career that shines brightly, Dr. Parmar has touched the lives of thousands of patients, leaving a lasting impact with his surgical skills and extensive experience. His unwavering enthusiasm has driven him to harness the full potential of medical science and technology to deliver enhanced patient care.

Dr. Parmar's illustrious journey is characterized by a profound mission — to extend the benefits of comprehensive eye care to individuals from all walks of life, irrespective of their socio-economic backgrounds. His commitment to community ophthalmology reflects a passion to make a meaningful difference in the world of eye health.

Under Dr. Parmar's visionary leadership, we are committed to providing the highest standard of eye care, embracing innovation, and upholding a compassionate approach to patient well-being. Our focus is clear: to illuminate the path toward better vision and brighter tomorrows.

Explore the world of eye care with Dr. Vimal K Parmar, where excellence meets compassion.

Contact Us to schedule a consultation and experience the pinnacle of eye care expertise. Your vision is our mission.

INTERNATIONAL PAPERS

We are delighted to present a noteworthy achievement in the realm of ophthalmology, exemplifying our unwavering commitment to advancing eye care. The research, "Safety and Efficacy of Razumab™ (the world's first biosimilar ranibizumab) in Wet Age-Related Macular Degeneration: A Post-Marketing, Prospective ASSET Study," marks a significant milestone in our journey.

This international study, co-authored by Dr. Vimal Parmar, delves into the safety and efficacy of Razumab™, a revolutionary medicine designed to address wet age-related macular degeneration (Wet AMD). This condition has long been a concern for eye health, and the introduction of a biosimilar ranibizumab like Razumab™ has been a game-changer.

Our research scrutinizes the medicine's dosages, ensuring its optimal use and maximal benefit to patients. At Mahaveer Eye Hospital, we are proud to contribute to the global body of knowledge in ophthalmology, enabling us to offer the best possible treatments and care.

This research is a testament to our commitment to excellence and our relentless pursuit of innovative solutions. As we continue to push the boundaries of eye care, we invite you to explore the promising world of Razumab™ and our ongoing dedication to your vision health.